Macrophage migration inhibitory factor (MIF) has widespread actions in the immune, endocrine and nervous systems. Previously, we reported that increases in the intracellular levels of MIF depress the firing of hypothalamus/brainstem neurons in culture, including the chronotropic actions of angiotensin II (Ang II). Lastly, the increase in I Kv produced by rMIF was abolished by the superoxide scavenger Tiron (1 mM). These studies indicate that the neuronal action of MIF includes a stimulatory action on I Kv that may be mediated via a TPOR/superoxide-scavenging mechanism.
INTRODUCTION
different modes of action has led to the idea that MIF may have a dual role in controlling cell function: as an extracellular cytokine and an intracellular enzyme (Mitchell 2004) .
With regard to enzymatic actions it is known that the MIF molecule exhibits distinct tautomerase and thiol-oxidoreductase activities. MIF can catalyze the tautomerization of phenylpyruvate and non-physiological substrates such as D-dopachrome (Rosengren et al. 1997) , and it is established that the N-terminal proline residue of MIF is critical for this tautomerase activity (Bendrat et al. 1997; Lubetsky et al. 1999) . By contrast, the thiolprotein oxidoreductase (TPOR) activity of MIF is exerted via cysteines at residues 57 and 60 of the MIF molecule (Kleemann et al. 1998) , and one potential consequence of an increase in TPOR activity is scavenging of reactive oxygen species (ROS) and blockade of oxidant-mediated intracellular actions (Sun et al. 2004; Nguyen et al. 2003a ).
Our interest in MIF stems from its interactions with the peptide angiotensin II (Ang II).
First, we demonstrated that Ang II increases the intracellular levels (but not secretion) of MIF in neurons cultured from newborn rat hypothalamus and brainstem (Sun et al. 2004) .
Subsequently, we have demonstrated that MIF exhibits differential effects on neuronal activity. Intracellular (but not extracellular) application of concentrations of MIF that exceed 8 nM elicit decreases in basal neuronal firing, while lower concentrations of MIF (~0.8 nM) depress the chronotropic action of Ang II (Sun et al. 2004) . The latter finding indicates that MIF may serve as a negative regulator of the neuronal actions of Ang II (Sun et al. 2004 ). In addition, the inhibitory action of MIF on Ang II's chronotropic actions appears to involve the TPOR activity of the MIF molecule, and possible scavenging of ROS (Sun et al. 2004) . In the present study we have focussed on understanding the fundamental membrane mechanisms by which MIF depresses basal neuronal firing. Specifically, we have investigated the effects of MIF on neuronal outward K + currents, changes of which contribute to alterations in neuronal firing (Wang JN-00499-2005 .R2
METHODS

Materials
One-day-old Sprague-Dawley (SD) rats were obtained from our breeding colony, which originated from Charles River Laboratories (Wilmington, MA). Dulbecco's modified Eagle's medium (DMEM) was obtained from Invitrogen (Grand Island, NY).
Crystallized trypsin was from Worthington Biochemicals (Freehold, NJ). Rabbit anti-rat MIF antibody was purchased from Torrey Pines Biolabs (Houston, TX). Plasma-derived horse serum (PDHS), deoxyribonuclease I (DNase I), -cytosine arabinoside (ARC), 4,5-dihydroxy-1,3-benzene-disulfonic acid (Tiron) and all other chemicals were obtained from Sigma Chemical (St. Louis, MO). Mouse recombinant MIF (rMIF), P1S-MIF and C60S-MIF mutants were prepared from an Escherichia coli expression system and purified free of endotoxin by C8 chromatography as described previously (Bernhagen et al. 1994; Kleemann et al.,1999 ) that, to date, has not been found to affect the influence of the bioactivity or immunoreactivity of the protein in different murine assays (Bernhagen et al. 1994; Bacher et al. 1997 ). D-dopachrome tautomerase (DCT), which shares 27% sequence identity with MIF and is essentially identical in three-dimensional architecture, was prepared by PCR cloning from mouse cDNA, and its structural fidelity was established by DNA sequencing. The recombinant protein was purified from an E.
coli expression system by sequential Mono-Q and C8 column FPLC followed by slow refolding from DTT/urea. These procedures closely followed those described previously for recombinant MIF (Bernhagen et al. 1994) . The peptide fragments of rat MIF (Sakai et al. 1994), MIF-(50-65) , and C57S/C60S-MIF-(50-65) were synthesized by the Tufts University Core Facility (Boston, MA). These peptides were unmodified at the N and C termini. Structures are as follows. MIF-(50-65): Total K + current was recorded by stepping from -80 mV to + 10 mV for 100 ms every min. I Kv was measured directly by stepping from a holding potential of -40 mV to +10 mV for 100 ms. In order to inactivate I A , depolarizing prepulses to -40 mV from the holding potential of -70 mV were applied for 50 msec (Zhu et al. 2000) . For total K + current and I Kv , current amplitudes were measured at 50 ms from the onset of the test pulse. Current density was derived by dividing current amplitude (pA) by membrane capacitance (pF), which was measured by using the Membrane test of pCLAMP 8.0. The average cell capacitance for neurons used in this study was 29.4 ± 1.2 pF (n = 110, range from 12 to 68 pF). I A was elicited by depolarization of the membrane potential to +42.5 mV for 100 ms from a holding potential of -110 mV every 1 min (Wang et al. 1997) . I A amplitude was measured as the peak current during the depolarizing pulse.
Drug applications
rMIF, MIF peptides, or anti-MIF antibodies were dissolved/diluted in pipette solution and injected intracellularly via the patch pipette as detailed by us previously (Sun et al. 2004; Zhu et al. 2000) . In brief, a side arm pipette holder was attached to the head stage of the Axopatch. One side arm was used to supply suction for seal formation, and JN-00499-2005.R2 a second side arm was used to advance a very fine polyethylene catheter (PE-50) down the inside of the patch pipette. Neurons were allowed to stabilize for 5 mins following establishment of the whole cell configuration. Next, control (baseline) measurements were made for 5 min, and after this pipette solution (5 µl) containing either rMIF, MIF mutants, MIF peptides, anti-MIF antibodies, or DCT was injected into the tip of the recording electrode via the PE-50 tube. From the electrode tip, the proteins, peptides, antibodies were allowed to diffuse into the neuron and measurements of K + were made.
Care was taken not to overperfuse the neuron, and this was monitored electronically via the Axopatch 200B and on the television monitor. Thus the concentrations of proteins, peptides and antibodies that are given in the results refer to the amounts injected at the pipette tip, and so are likely higher than the amounts that reach the site of action.
Data analyses
Results are expressed as means ± SE. Statistical significance was evaluated with ANOVA1 and paired Student's t-test. Differences were considered significant at P < 0.05; n refers to the number of cells examined.
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RESULTS
MIF increases neuronal I Kv , but not neuronal I A
In previous studies we had demonstrated that intracellular, but not extracellular, this data may suggest that other mechanisms, in addition to I Kv , may mediate the depressant effect of rMIF on basal neuronal firing. In addition, our data indicate that rMIF (80 nM) that had been denatured by boiling for 20 mins did not alter I Kv (Fig. 2) . In order to determine whether the augmentation of I Kv by rMIF is caused by a shift in the voltage dependence of activation to more negative potentials, the voltage dependence of I Kv was compared before and after treatment of neurons with rMIF. I Kv density was calculated and plotted against the membrane potential. Under control conditions, I Kv activated at potentials greater than -40 mV (Fig. 3) . rMIF (80 nM) did not significantly change the threshold of I Kv , but significantly increased the amplitude and density of I Kv at all tested potentials. The increase of I Kv produced by rMIF (80 nM) was abolished by simultaneous JN-00499-2005.R2 administration of MIF neutralizing antibodies (1:100 dilution; P<0.05) but not by control IgG (1:100), indicating the specificity of this MIF action (Fig. 4) .
In contrast to its stimulatory effect on I Kv , intracellular application of rMIF produced no changes in I A , another outward K + current that is involved in the regulation of neuronal firing. Direct measurements of I A clearly demonstrate that intracellular application of rMIF (80 nM) does not significantly alter this current (Fig. 5A,B ). This was confirmed by analyses of the effects of rMIF on total K + current, which demonstrated that intracellular application of rMIF (80 nM) produced a significant increase in I Kv rather than alter I A (Fig.   5C ,D).
Mechanism of MIF-induced increases in neuronal I Kv
Our previous studies indicated that the inhibitory effect of rMIF on Ang II's neuronal While the studies presented here provide the first demonstration of MIF effects on a neuronal membrane ionic current, a number of issues are also raised. One immediate issue concerns the discrepancy between the concentration of MIF required to reduce the basal firing (~ 8 nM) and that which produced an increase in I Kv (80 nM). If the change in I Kv is linked to the change in neuronal firing, then it is difficult to resolve the difference in the concentration of rMIF required to produce a change in each case. Since changes in neuronal firing can be achieved by alterations in the activities of other ionic channels as well, one possibility is that some of these channels have even higher sensitivity to rMIF than I Kv . In this regard determination of the effects of rMIF on neuronal Ca 2+ currents is a part of our ongoing studies.
The data presented here has provided insight into the intracellular mechanisms by which MIF increases neuronal I Kv . It is well-known that MIF exhibits two major enzymatic activities: a tautomerase activity mediated through the N-terminal proline residue (Pro-1) of the molecule (Rosengren et al. 1997; Bendrat et al. 1997; Lubetsky et al. 1999) , and a thiol-protein oxidoreductase activity associated with residues 57-60 (Cys-Ala-Leu-Cys) (Kleemann et al. 1998; Nguyen et al. 2003b) . Our previous studies indicated that the TPOR activity is responsible for the inhibitory action of rMIF on the neuronal chronotropic effect of Ang II (Sun et al. 2004 ). The present data indicate that the MIF mutant P1S-MIF and the peptide MIF-(50-65), both of which exhibit TPOR activity, mimic the effects of rMIF on neuronal I Kv . Conversely, the MIF mutant C60S-MIF and the MIF homologue DCT, both of which exhibit MIF-like tautomerase activity but lack TPOR activity, fail to alter neuronal I Kv . Collectively, these data indicate that rMIF increases I Kv via the TPOR activity within its molecule. However, an issue concerning the present data is that 10-fold greater levels of MIF- (50-65) et al. 2002) , and also that ROS can alter K + channel activity (Kourie 1998).
More recently, our group has demonstrated that ROS (superoxide, but not H 2 O 2 ) inhibits neuronal I Kv via a direct action at Kv channels (Sun et al., 2005) . Here, we have demonstrated that MIF fails to increase neuronal I Kv in cells that have been exposed to a superoxide-scavenging agent. Therefore, this data supports the idea that rMIF increases I Kv (and subsequently reduces basal neuronal firing) by scavenging ROS.
Despite this finding, other intracellular actions of MIF to increase I Kv (e.g. via interaction with other factors that modulate channel activity) cannot be excluded at this point.
The finding that rMIF does not produce any changes in I A was surprising, when considering that this current also has a role in neuronal activation. The reasons that MIF fails to influence the activity of I A are unknown at this point. However, one possibility is that ROS play little or no role in the regulation of I A in these cells, and if this is the case, then MIF may not be expected to influence I A .
In conclusion, these data provide the first demonstration that MIF, acting intracellularly, produces a specific modulatory action on one of the K + currents that is the basis of the neuronal action potential and thus neuronal firing. Consequently, this 
